WMSA
AEGR

Weiss Multi-Strategy Advisers’s Aegerion Pharmaceuticals AEGR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-25,000
Closed -$340K – 500
2015
Q3 		$340K Buy
+25,000
New +$445K 0.02% 347

Other funds holding AEGR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AEGR Position: Q2 2015 in Review

Weiss Multi-Strategy Advisers sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2015, closing a stake of 19,000 shares — an estimated $497K sold.

Weiss Multi-Strategy Advisers first reported a position in AEGR in Q4 2013 and held it in 6 quarters. The position peaked at $1.37M in Q1 2014. 97 funds tracked by Wall St. Rank hold AEGR as of Q2 2015.

  • Weiss Multi-Strategy Advisers reported no remaining Aegerion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 19,000 Aegerion Pharmaceuticals shares in Q2 2015, an estimated $497K.
  • Weiss Multi-Strategy Advisers first reported a position in Aegerion Pharmaceuticals in Q4 2013 and held it in 6 quarters.
  • Weiss Multi-Strategy Advisers's Aegerion Pharmaceuticals position peaked at $1.37M in Q1 2014.
  • 97 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2015, filed 14 Aug 2015.